Patents by Inventor Michael Bergelson

Michael Bergelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7848813
    Abstract: A patient monitor is configured to interrogate an implantable medical device (IMD) and receive data from the IMD in response to the interrogation. The data received from the IMD includes electrogram (EGM) data, which the patient monitor frequency modulates for transmission, in real-time, onto a conventional telephone line. The frequency modulated EGM data that is transmitted from the patient monitor may in turn be displayed, in real-time, at a remote monitoring station in response to commands provided by a remote (DTMF) signal from a receiving station.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: December 7, 2010
    Assignee: Medtronic, Inc.
    Inventors: Michael Bergelson, Narcis M. Naydenov
  • Patent number: 7299085
    Abstract: An integrated device for remote monitoring of implanted medical devices and surface ECG information includes components for collection of information from an implanted medical device, collection of surface ECG information, and remote communication of the collected information to a remote monitoring station. The remote monitoring station controls operation of the integrated device to automatically acquire the information without substantial patient intervention. In this manner, the device promotes accurate and timely collection of the information, and reduced depletion of battery resources within the implanted medical device.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: November 20, 2007
    Assignee: Medtronic, Inc.
    Inventors: Michael Bergelson, Narcis M. Naydenov
  • Patent number: 7218967
    Abstract: A patient monitor is configured to interrogate an implantable medical device (IMD) and receive data from the IMD in response to the interrogation. The data received from the IMD includes electrogram (EGM) data, which the patient monitor frequency modulates for transmission, in real-time, onto a conventional telephone line. The frequency modulated EGM data that is transmitted from the patient monitor may in turn be displayed, in real-time, at a remote monitoring station in response to commands provided by a remote (DTMF) signal from a receiving station.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: May 15, 2007
    Assignee: Medtronic, Inc.
    Inventors: Michael Bergelson, Narcis M. Naydenov
  • Publication number: 20070106346
    Abstract: A patient monitor is configured to interrogate an implantable medical device (IMD) and receive data from the IMD in response to the interrogation. The data received from the IMD includes electrogram (EGM) data, which the patient monitor frequency modulates for transmission, in real-time, onto a conventional telephone line. The frequency modulated EGM data that is transmitted from the patient monitor may in turn be displayed, in real-time, at a remote monitoring station in response to commands provided by a remote (DTMF) signal from a receiving station.
    Type: Application
    Filed: October 31, 2006
    Publication date: May 10, 2007
    Inventors: Michael Bergelson, Narcis Naydenov
  • Publication number: 20060106645
    Abstract: A method for tracking a patient's medical encounters includes storing a record identifying the patient in a database, receiving notification of a medical encounter between the patient and a healthcare provider, adding encounter information to the record to generate an updated record, and storing the updated record. The method also includes reporting the encounter information to the patient or to an authorized third party. A business method and system for tracking a patient's medical encounters also are disclosed.
    Type: Application
    Filed: November 17, 2004
    Publication date: May 18, 2006
    Applicant: ADHD Systems, LLC
    Inventors: Michael Bergelson, Andreas Theodosiou
  • Publication number: 20050070968
    Abstract: A patient monitor is configured to interrogate an implantable medical device (IMD) and receive data from the IMD in response to the interrogation. The data received from the IMD includes electrogram (EGM) data, which the patient monitor frequency modulates for transmission, in real-time, onto a conventional telephone line. The frequency modulated EGM data that is transmitted from the patient monitor may in turn be displayed, in real-time, at a remote monitoring station in response to commands provided by a remote (DTMF) signal from a receiving station.
    Type: Application
    Filed: September 26, 2003
    Publication date: March 31, 2005
    Inventors: Michael Bergelson, Narcis Naydenov
  • Publication number: 20040215089
    Abstract: An integrated device for remote monitoring of implanted medical devices and surface ECG information includes components for collection of information from an implanted medical device, collection of surface ECG information, and remote communication of the collected information to a remote monitoring station. The remote monitoring station controls operation of the integrated device to automatically acquire the information without substantial patient intervention. In this manner, the device promotes accurate and timely collection of the information, and reduced depletion of battery resources within the implanted medical device.
    Type: Application
    Filed: April 23, 2003
    Publication date: October 28, 2004
    Inventors: Michael Bergelson, Narcis M. Naydenov
  • Patent number: 4493327
    Abstract: Disclosed are a method and a system for determining if a patient's brain electrical activity reflects a significant evoked response to a sensory stimulus. A test measure of the difference between two sets of averaged waveforms, one in the absence and another in the presence of the stimulus, is derived on the basis of (i) mean values of spectral measures of the two sets and (ii) the variance of these spectral measures. This test measure is matched against acceptance and rejection levels which are defined on the basis of both (i) the number of averaged waveforms in each set and (ii) the desired degree of probability of avoiding false positive or false negative results.
    Type: Grant
    Filed: July 20, 1982
    Date of Patent: January 15, 1985
    Assignee: Neurometrics, Inc.
    Inventors: Michael Bergelson, Jacob Fridman, Erwin R. John